Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 26, 2023

Glenmark Generics Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-seven approved drugs.

There are two tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics

US Patents:	0
Tradenames:	58
Ingredients:	53
NDAs:	67

Drugs and US Patents for Glenmark Generics

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Generics	ASHLYNA	ethinyl estradiol; levonorgestrel	TABLET;ORAL	203163-001	Feb 23, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Glenmark Generics	CICLOPIROX	ciclopirox	GEL;TOPICAL	091595-001	Feb 29, 2012	AB	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
Glenmark Generics	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	201967-001	Dec 31, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Glenmark Generics	ESZOPICLONE	eszopiclone	TABLET;ORAL	091166-001	Apr 15, 2014	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Glenmark Generics	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	077987-001	May 11, 2007	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Glenmark Generics	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	090135-002	Feb 25, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

McKesson

Boehringer Ingelheim

McKinsey

AstraZeneca

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.